Mycoses · 2019 · 25 citations · 25 references
Life SciencesInfectious DiseasesMicrobiologyInfectious Disease EpidemiologyMedical MicrobiologyMycologyDisease Risk AssessmentFungal InfectionsFungal PathogenesisFungal PathologyFungal ZoonosesOpportunistic InfectionsChronic Granulomatous DiseaseFungal Infections In Immunocompromised HostsFungal Infections In Transplant RecipientsInfection Risk FactorsInvasive Fungal InfectionsInvasive InfectionInvasive Pulmonary Fungal InfectionOverall Mortality
BACKGROUND: The new Rasamsonia spp. complex can develop invasive infection in immunosuppression or chronic pulmonary disease. It has potential to be misidentified as other genera due to morphological similarities. Nowadays, there is a gap of knowledge on this fungi. OBJECTIVES: To provide knowledge base of risk factors and therapeutic decisions in invasive Rasamsonia spp. complex infection. PATIENTS/METHODS: registry and all reported cases from a literature were included. RESULTS: registry. Main risk factors were chronic granulomatous disease (n = 12, 52.2%), immunosuppressive treatment (n = 10, 43.5%), haematopoietic stem cell transplantation (n = 7, 30.4%), graft-versus-host disease and major surgery (n = 4, 17.4%, each). Predominantly affected organs were the lungs (n = 21, 91.3%), disease disseminated in seven cases (30.4%). Fungal misidentification occurred in 47.8% (n = 11), and sequencing was used in 69.6% of the patients (n = 16) to diagnose. Breakthrough infection occurred in 13 patients (56.5%). All patients received antifungal treatment, mostly posaconazole (n = 11), caspofungin (n = 10) or voriconazole (n = 9). Combination therapy was administered in 13 patients (56.5%). Susceptibility testing showed high minimum inhibitory concentrations for azoles and amphotericin B, but not for echinocandins. No preferable treatment influencing favourable outcome was identified. Overall mortality was 39% (n = 9). CONCLUSION: Rasamsonia spp. are emerging fungi causing life-threatening infections, especially in immunocompromised and critically ill patients. Mortality is high. Treatment is challenging and clinicians dealing with this patient population should become aware of this infection constituting a medical emergency.
25
Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2008 · 4.9K citations · Full text
J. Peter Donnelly, Sharon Chen, Carol A. Kauffman et al. · Clinical Infectious Diseases · 2019 · 2.8K citations · Full text
Fungal Planet description sheets: 214–280
P.W. Crous, Roger G. Shivas, William Quaedvlieg et al. · Persoonia - Molecular Phylogeny and Evolution of Fungi · 2014 · 408 citations · Full text
Fungal Planet description sheets: 400–468
P.W. Crous, M.J. Wingfield, David M. Richardson et al. · Persoonia - Molecular Phylogeny and Evolution of Fungi · 2016 · 260 citations · Full text
Shahid Husain, Martha L. Mooney, Lara Danziger‐Isakov et al. · The Journal of Heart and Lung Transplantation · 2011 · 226 citations · Full text
Life Sciences, Infectious Diseases, Infectious Disease Epidemiology +16